Automate Visual Inspection and Viscosity and Take an Early Day Today  
Unchained Labs Logo
July 19, 2018
11 am to 12 pm EDT



Webinar Description:
Visual inspection and viscosity measurements are key to fully understanding the stability and developability of biologic candidates and formulations. Automation removes the qualitative nature of color matching and visual inspection. Viscosity measurements can be automated as well, reducing the need for hands on time to make these basic developability measurements.

A Junior automation platform combines a visual inspection station and a capillary viscometer into one walk away system. With the visual inspection station, a researcher can perform visible particle counting, color matching, and turbidity of hundreds of vialed samples non-destructively, preserving sample for further analytics. The viscosity station requires only 100 µL of sample to obtain a measurement and automatically cleans between samples, providing insight into the developability of a formulation while minimizing waste of precious sample.

We will provide an overview of the automated system and show some proof of concept data for how these can be combined to streamline biologic formulation developability assessments.

Learning Objectives

  • See how the Junior can automate visual inspection and viscosity analysis
  • Learn how to quickly evaluate stability with automated non-destructive visual inspection
  • Learn how to automate viscosity analysis with only 100 µL of sample
  • See how this can all be combined to streamline formulation assessment


Robin Sweeney, PhD
Automation Applications Scientist
Unchained Labs

Robin Sweeney is an Automation Applications Scientist at Unchained Labs. Robin earned a BS in Biology and Biomathematics from The University of Scranton and a PhD in Biomedical Engineering from the Univsity of Arizona. Her graduate research focused on optical biosensor and immunoassay development. At Unchained Labs, Robin focuses on applications of our automation platforms toward biologic drug development.